
Alert: New Earnings Report (2/26/25)-Acadia Pharmaceuticals Inc (NASDAQ: ACAD).
For its fourth fiscal quarter (ending December 31), Acadia Pharmaceuticals Inc (NASDAQ: ACAD) has reported a 207% increase in E.P.S. from $0.28 a year ago to $0.86 in the current quarter. E.P.S. were $1.37 for […]